Contract Research & Services
Contract Research

Bioanalysis of Biosimilars

Published 03 August 2015 | By PRA Health Sciences

Assessment of biosimilarity during non-clinical and clinical trials requires specific bioanalytical procedures. The concentration of the biosimilars and their reference compounds is established using pharmacokinetic (PK) methods. Immunogenicity assays are used to determine and further characterize any anti-drug antibodies (ADA) formed during these studies. These analytical methods are pivotal for establishing similarity of biosimilar products as compared to their reference compounds.

Available Downloads

Bioanalysis of Biosimilars